Efficacy and Safety of Combination Antifungals as Empirical, Preemptive, and Targeted Therapies for Invasive Fungal Infections in Intensive-Care Units

Efficacy and Safety of Combination Antifungals as Empirical, Preemptive, and Targeted Therapies for Invasive Fungal Infections in Intensive-Care Units

Qianting Yang, Jiao Xie, Yan Cai, Na Wang, Yan Wang, Li Zhang, Youjia Li, Jingjie Yu, Ya Li, Haitao Wang, Kanghuai Zhang Department of Pharmacy, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, People’s Republic of ChinaCorrespondence: Kanghuai Zhang, Department of Pharmacy, The S...

Full description

Bibliographic Details
Main Authors:	Yang Q, Xie J, Cai Y, Wang N, Wang Y, Zhang L, Li Y, Yu J, Wang H, Zhang K
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-09-01
Series:	Infection and Drug Resistance
Subjects:	caspofungin voriconazole amphotericin b liposome combination therapy invasive fungal infection intensive-care units
Online Access:	https://www.dovepress.com/efficacy-and-safety-of-combination-antifungals-as-empirical-preemptive-peer-reviewed-fulltext-article-IDR

Similar Items

Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole
by: Jia Chen, et al.
Published: (2014-10-01)

Epidemiology and Antifungal Susceptibility of Candida Species Isolated from 10 Tertiary Care Hospitals in Iran
by: Parisa Badiee, et al.
Published: (2022-12-01)

THE IMPACT OF ANTIFUNGALS ON TOLL-LIKE RECEPTORS
by: Mircea Radu Mihu, et al.
Published: (2014-03-01)

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans
by: Gerardo Becerra Victorio, et al.

Intravitreal injection of drugs combined with vitrectomy on fungal endophthalmitis
by: Xiao-Dong Li
Published: (2017-03-01)

The high efficacy of luliconazole against environmental and otomycosis Aspergillus flavus strains
by: Maryam Moslem, et al.
Published: (2020-04-01)

Two cases of aspergillus endocarditis in non neutropenic children on chemotherapy for acute lymphoblastic leukaemia.
by: Emmanouil Nikolousis, et al.
Published: (2011-06-01)

Osteoarticular Candida Infection: Report of Three Cases and Literature Review of 44 Patients
by: Firdevs AKSOY, et al.
Published: (2019-12-01)

Fungal infections of the orbit
by: Bipasha Mukherjee, et al.
Published: (2016-01-01)

Pyrenocheata unguis-hominis: A new cause of fungal keratitis in a contact lens wearer
by: Sima Nissan, et al.
Published: (2022-12-01)

In vitro and in vivo evaluation of antifungal combinations against azole-resistant Aspergillus fumigatus isolates
by: Sana Jemel, et al.
Published: (2023-01-01)

Successful caspofungin treatment of persistent candidemia in extreme prematurity at 23 and 24 weeks' gestation
by: Ga Won Jeon, et al.
Published: (2014-03-01)

Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis
by: Döring Michaela, et al.
Published: (2012-07-01)

Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections
by: Yuanming Xing, et al.
Published: (2017-12-01)

Two Case of Rino-Orbito-Cerebral Mucormycosis Developing Secondary to Diabetic Ketoacidosis
by: Yeliz ÖZDEMİR, et al.
Published: (2024-03-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

Amphotericin B May Decrease the Serum Level of Voriconazole: A Case Report and Brief Review of Literature
by: Hu Z, et al.
Published: (2022-09-01)

Pharmacotherapy of Fungal Keratitis
by: A. S. Obrubov, et al.
Published: (2018-04-01)

Dectin-2-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy
by: Suresh Ambati, et al.
Published: (2019-10-01)

A pharmacoeconomic evaluation of capsofungin and amphotericin B for intravenous infusion for treatment of systemic fungal infection
by: Živković Marija, et al.
Published: (2015-01-01)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
by: Nur Efe İris, et al.
Published: (2016-11-01)

Growth and Antifungal Resistance of the Pathogenic Yeast, <i>Candida Albicans</i>, in the Microgravity Environment of the International Space Station: An Aggregate of Multiple Flight Experiences
by: Sheila Nielsen, et al.
Published: (2021-03-01)

Adverse Effects Associated With Currently Commonly Used Antifungal Agents: A Network Meta-Analysis and Systematic Review
by: Yan-Li Yang, et al.
Published: (2021-10-01)

Impact of Anti-Mycotic Drugs on the Osteogenic Response of Bone Marrow Mesenchymal Stem Cells In Vitro
by: Tim Niklas Bewersdorf, et al.
Published: (2024-02-01)

Evaluation of liposomal amphotericin B for the treatment of fungal keratitis in a tertiary eye care hospital
by: Vishal Kumar, et al.
Published: (2023-01-01)

In vitro susceptibility of Cuban Aspergillus spp. strains of clinical and environmental origin
by: Javier L. San Juan, et al.
Published: (2017-12-01)

Comparative Evaluation of Disc Diffusion and E-test with Broth Micro-dilution in Susceptibility testing of Amphotericin B, Voriconazole and Caspofungin against Clinical Aspergillus isolates
by: Prashant Gupta, et al.
Published: (2015-01-01)

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry
by: Egerer Gerlinde, et al.
Published: (2012-04-01)

A rare case of scedosporium apiospermum osteomyelitis in an immunocompetent patient
by: Aayushi J. Rajani, et al.
Published: (2024-01-01)

Is Halving Maintenance of Voriconazole Safe and Efficient in Patients Suffering from Invasive Fungal Infections with Serious Hepatic Dysfunction?
by: Cai X, et al.
Published: (2023-01-01)

Caspofungin pharmacokinetics and probability of target attainment in ICU patients in China
by: Fangyi Li, et al.
Published: (2021-06-01)

MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method
by: Andrew M. Borman, et al.
Published: (2017-05-01)

Are Systemic Voriconazole and Caspofungin Ototoxic? An Experimental Study with Rats
by: Emine Aydın, et al.
Published: (2012-09-01)

Phenotypic identification and antifungal susceptibility patterns of Candida species isolated from various clinical specimens in Suez Canal University Hospitals
by: Samaa Aboueldahab, et al.
Published: (2023-05-01)

Sección 4. Consenso colombiano para el diagnóstico y tratamiento de los síndromes crónicos, saprofíticos y/o alérgicos asociados a Aspergillus spp., en pacientes adultos y pediátricos
by: José M. Oñate G
Published: (2022-07-01)

Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges
by: Nancy N. Vuong, et al.
Published: (2023-04-01)

Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)

Comparative efficacy and tolerability of amphotericin B lipid complex and liposomal amphotericin B in the treatment of invasive fungal infections in patients with hematological malignancies: literature review
by: N. V. Dmitrieva, et al.
Published: (2014-07-01)

In Vitro and In Vivo Evaluation of Voriconazole-Containing Antifungal Combinations against Mucorales Using a Galleria mellonella Model of Mucormycosis
by: Daiana Macedo, et al.
Published: (2019-01-01)